Medicina nuclear

1992

1. A clinical and laboratory evaluation of the behavior of tissue polypeptide antigen in liver cirrhosis

   Digestion, Vol. 53, Núm. 3-4, pp. 157-161

2. Breast cancer-associated antigen ca 15.3 in liver cirrhosis

   Acta Oncologica, Vol. 31, Núm. 7, pp. 741-744

3. CA 125 serum levels in patients with non-neoplastic liver diseases. A clinical and laboratory study

   Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 52, Núm. 3, pp. 201-206

4. CA 19-9 in non-neoplastic liver diseases. A clinical and laboratory study

   Clinica Chimica Acta, Vol. 210, Núm. 1-2, pp. 145-151

5. CEA serum levels in non-neoplastic disease

   International Journal of Biological Markers, Vol. 7, Núm. 3, pp. 160-166

6. Evaluation of the behavior of carcinoembryonic antigen in cirrhotic patients

   International Journal of Biological Markers, Vol. 7, Núm. 4, pp. 244-248

7. Monitoring endometrial adenocarcinoma with a four tumor marker combination: CA125, squarnous cell carcinoma antigen, CA19.9 and CA15.3

   Acta Obstetricia et Gynecologica Scandinavica, Vol. 71, Núm. 6, pp. 458-464

8. Preliminary study of alpha-fetoprotein in nonmalignant liver diseases. A clinico-biochemical evaluation

   International Journal of Biological Markers, Vol. 7, Núm. 2, pp. 97-102

9. Prostatic cancer: biological aspects of clinical interest

   Medicina clínica, Vol. 99, Núm. 17, pp. 664-667

10. Quantification and molecular analysis of cathepsin D in breast cyst fluids

    European Journal of Cancer, Vol. 28, Núm. 4-5, pp. 828-832

11. Serum prolactin levels in women with gross cystic breast disease

    International Journal of Biological Markers, Vol. 7, Núm. 4, pp. 225-229

12. Tissue polypeptide antigen (TPA) in chronic active hepatitis and mild liver diseases

    International Journal of Biological Markers, Vol. 7, Núm. 4, pp. 249-252